Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Related Keywords

Japan ,Germany ,Saudi Arabia ,United States ,France ,Australia ,China ,Norway ,Italy ,Kingdom Of Saudi Arabia ,American ,Dave Risinger ,Mikael Dolsten ,Chris Shibutani Goldman Sachs ,Rajesh Kumar ,Carter Gould Barclays ,Carter Gould ,Chris Schott ,Francesca Demartino ,Chris Shibutani ,Terence Flynn Morgan Stanley ,Louise Chen Cantor Fitzgerald ,Christ Schott Jpmorgan ,Akash Tewari Jefferies ,Srikripa Devarakonda ,Akash Tewari ,Doug Lankler ,Rd Doug Lankler ,Mohit Bansal ,Evan Seigerman ,Geoff Meacham ,Dave Risinger Leerink ,Trung Huynh ,Terence Flynn ,Tim Anderson ,Louise Chen ,America Merrill Lynch ,Dave Denton ,Chris Boshoff ,Aamir Malik ,Albert Bourla ,Steve Scala ,Srikripa Devarakonda Truist ,Vaccine Technical Committee ,Company Analyst ,Pfizer ,Barclays ,Nvidia ,American Society Of Clinical Oncology ,Geoff Meacham Bank ,Morgan Stanley ,Tim Anderson Wolfe Research Analyst ,Goldman Sachs ,Wolfe Research ,Pfizer International ,Wells Fargo ,Investor Relations ,Motley Fool Stock Advisor ,Stock Advisorservice ,Stock Advisor ,Alexandre De Germay ,Chief Executive ,Oncology Innovation Day ,Inflation Reduction Act ,American Society ,Clinical Oncology ,Pfizer International Commercial ,Vice President ,Chief International Commercial ,Chief Oncology ,New England Journal ,Vamil Divan ,Maybe Alexandre ,Scientific Officer ,Umer Raffat ,Lilly Direct ,Fargo Securities ,Breakthrough Designation ,Chief Business ,Executive Vice President ,Guggenheim Partners ,Leerink Partners ,Chief Scientific Officer ,Truist Securities ,Wells Fargo Securities ,Chief Executive Officer ,Investor Relations Officer ,